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Objectives We evaluated whether appropriateness and baseline risk of cardiac catheterization varied according to regional
intensity of invasive therapy after acute myocardial infarction (AMI), and whether AMI mortality varied according
to invasive intensity regions.
Background Marked regional variations exist in cardiac invasive procedure use after AMI within the U.S.
Methods We performed an analysis of 44,639 Medicare fee-for-service beneficiaries hospitalized with AMI between 1998
and 2001. Invasive procedure intensity was determined based on overall cardiac catheterization rates for Medi-
care enrollees. Cardiac catheterization appropriateness was determined by the American College of Cardiology/
American Heart Association classification and baseline risk was estimated using the GRACE (Global Registry of
Acute Coronary Events) risk score. The primary outcomes of the study were cardiac catheterization use within 60
days and 3-year mortality after hospital admission.
Results Higher invasive intensity regions were more likely to perform cardiac catheterizations on class I patients (appro-
priate) (RR 1.38, 95% confidence interval [CI] 1.27 to 1.48), class II patients (equivocal) (RR 1.42, 95% CI 1.31
to 1.53), and class III patients (inappropriate) (RR 1.29, 95% 0.97 to 1.67) compared with low-intensity regions
after adjusting for patient and physician characteristics. The overall cardiac catheterization use was 5.2% lower
for each increase in GRACE risk decile, and this relationship was observed similarly in all regions. Risk-
standardized mortality rates of AMI patients at 3 years were not substantially different between regions.
Conclusions Although higher-risk patients and those with more appropriate indications may have the most to benefit from an
invasive strategy after AMI, we found that higher-invasive regions do not differentiate procedure selection based
on the patients’ appropriateness or their baseline risks. (J Am Coll Cardiol 2008;51:716–23) © 2008 by the
American College of Cardiology Foundation
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February 19, 2008:716–23 Cardiac Catheterization and Baseline Risklthough published recommendations on cardiac interven-
ional procedure indications and effectiveness are widely
vailable (1–3), marked regional variations exist in the use of
ardiovascular procedures (4,5). Indeed, previous evidence
as demonstrated that there exists a 2-fold regional differ-
nce in the use of cardiac catheterization after acute myo-
ardial infarction (AMI) within the U.S. (5,6). These
egional differences persist after adjusting for patient, phy-
ician, and hospital factors (4,6–8). However, the extent to
hich regional procedure variations may be attributed to
erforming cardiac catheterizations in AMI patients with
ifferent levels of procedure appropriateness or different
aseline risks is unknown. Specifically, are regions of higher
nvasive intensity more likely to perform cardiac catheter-
zations among more appropriate and higher-risk patients
here benefits are the largest? Alternatively, are regions of
ower invasive intensity more selective in performing cardiac
atheterization in more appropriate or higher-risk patients
ue to resource constraints?
Data evaluating the appropriateness of cardiac catheter-
zation use are mixed, with some studies reporting that
rocedures are used more appropriately in higher-invasive
egions and others finding no difference in their use (9–13).
n contrast, studies evaluating the relationship between
atients’ baseline risk and cardiac catheterization have
onsistently shown less frequent procedure use among
igher-risk patients (14,15), a subgroup that has been
emonstrated to benefit the most from an invasive strategy
3,16–18). However, none of these studies has investigated
hether this pattern varies by procedures performed per
apita within a particular region.
Accordingly, we sought to determine whether appropri-
teness of cardiac catheterization use varied according to
egional intensity of invasive therapy. Second, we examined
hether baseline risks of those who received cardiac cath-
terizations varied in different invasive regions. Third, we
xamined whether AMI patients hospitalized in higher
nvasive intensity regions had better long-term mortality
han those in lower-intensity regions. To address these
uestions, we used data from the National Heart Care
NHC) project, a Centers for Medicare and Medicaid
ervices initiative designed to improve the quality of care for
edicare beneficiaries hospitalized with AMI in the U.S.
ethods
he NHC project. The NHC project included a random
ample of Medicare fee-for-service beneficiaries hospital-
zed in March 1998 to April 1999 and March 2000 to April
001 with a principal discharge diagnosis of AMI (Inter-
ational Classification of Diseases-Ninth Revision-Clinical
odification [ICD-9-CM] code 410) from each state and
he District of Columbia (19).
tudy sample. The NHC study sample included patients
65 years of age who had a confirmed AMI, defined aslevation in troponin I or T level, creatine kinase–muscle- Irain isoenzyme fraction 0.05,
actate dehydrogenase (LDH)
evel of more than 1.5 times nor-
al with LDH1 levels greater
han those of LDH2, or 2 of the
ollowing 3 criteria: chest pain, a
-fold elevation of the creatine
inase level, or a new AMI doc-
mented on the official electro-
ardiogram report (19). We ex-
luded patients who had repeat
MI hospitalizations during the
tudy period to have each patient represented in the data-
ase with 1 index hospitalization. We did not investigate
he relationship of cardiac catheterization use and reinfarc-
ion. Patients who were transfered in from another hospital
ere excluded, because we did not have the medical records
hat described the hospitalization at the first hospital. We
lso excluded 1,998 patients because of the inability to
etermine cardiac catheterization utilization after hospital
ischarge. The demographics and clinical characteristics of
hese patients did not differ substantially from patients
ncluded in the study.
ppropriateness of cardiac catheterization. We evaluated
ardiac catheterization appropriateness based on the Amer-
can College of Cardiology/American Heart Association
ACC/AHA) guidelines and appropriateness criteria previ-
usly reported (Online Appendix) (10,20,21). The strong-
ndication group consisted of patients in whom cardiac
atheterization was generally recognized as “beneficial, use-
ul, and effective” (ACC/AHA class I). We did not include
reinfarction during hospitalization” as a class I indicator,
ecause this data field was not captured in our dataset. The
quivocal group (ACC/AHA class II) included patients
ho had conditions for which the effectiveness of cardiac
atheterization was unclear. The weak indication group
ACC/AHA class III) consisted of patients for whom
ardiac catheterization was considered unlikely to be effec-
ive (Online Appendix) (10,20,21).
aseline risk of AMI patients. We determined baseline
isk of hospitalized AMI patients using the GRACE
Global Registry of Acute Coronary Events) prediction risk
core (22). The GRACE mortality model was developed
sing an international registry of acute coronary syndrome
atients and includes prediction variables such as age,
dmission characteristics (heart rate, Killip class, systolic
lood pressure, cardiac arrest during presentation, ST-
egment deviation), and laboratory values (serum creatinine,
ositive cardiac markers) (22). Although the GRACE risk
core was developed using patients with acute coronary
yndrome, it has been validated in an AMI population (23).
utcomes. The primary outcome was the use of cardiac
atheterization within 60 days of AMI admission. Cardiac
atheterization use was determined by linking the hospital
edical record and Medicare Part A billing records for
Abbreviations
and Acronyms
ACC/AHA  American
College of Cardiology/
American Heart Association
AMI  acute myocardial
infarction
LDH  lactate
dehydrogenase
NHC  National Heart CareCD-9-CM codes associated with the procedure (37.22,
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Cardiac Catheterization and Baseline Risk February 19, 2008:716–237.33, 88.53 to 88.57). The secondary outcome was 3-year
ortality after AMI admission, as determined by the
edicare enrollment database and billing records.
egional intensity of cardiac invasive procedures. Hos-
ital referral regions (HRRs) are discrete geographic regions
efined on the basis of travel distance to tertiary care centers
mong Medicare beneficiaries (24). In each HRR, we first
etermined the number of cardiac catheterizations per-
ormed per Medicare enrollee residing in that area. We then
rranged HRRs into 3 groups to represent low, intermedi-
te, and high invasive intensity regions based on the number
f cardiac catheterizations performed per 1,000 Medicare
nrollee in each region (for example, low invasive intensive
egions had the lowest tertile of cardiac catheterizations
se). These data were obtained by linking our medical
ospitalization AMI records with the 1999 Aggregated
urgical Discharge Data File using residential or hospital
ip codes.
tatistical analysis. We first compared the demographic
nd clinical characteristics of AMI patients hospitalized in
egions of different invasive intensity. Categoric variables
ere compared among the 3 invasive regions using chi-
quare tests, and continuous variables were compared using
tests from analysis of variance.
We then developed multivariate regression models to
xamine the effects of regional invasive intensity on cardiac
atheterization use, adjusting for patient characteristics (age,
illip class, systolic blood pressure, heart rate, serum creat-
nine, cardiac resuscitation, ST-segment elevation, cardiac
nzymes, chronic obstructive pulmonary disease, dementia,
obility, urinary continence), and physician characteristics
age, gender, race, specialty). We also examined the effects
f regional intensity with mortality, adjusting for patient,
hysician, and hospital characteristics (mean AMI volume,
ardiac care facility level, teaching status). All analyses
ncorporated probability weights based on the inverse sam-
ling fraction for the population size of each state, and all
odels were adjusted for clustering. Odds ratios were
onverted to estimated relative risks (RRs) (25). Physician
haracteristics were obtained using the American Medical
ssociation Masterfile, and hospital data were obtained
rom the 1998 and 2000 American Hospital Association
urvey of Hospitals.
The relationship between cardiac catheterization use and
aseline risk in the 3 invasive intensity regions was first
xamined using scatterplots of cardiac catheterization rates
nd GRACE risk score deciles. We modeled the relation-
hip using multiple linear regression models with catheter-
zation use as the dependent variable and risk deciles as the
ndependent variables. A series of secondary analyses were
hen undertaken to examine the robustness of our results.
irst, we examined the relationship based on different
ppropriate cardiac catheterization indications. Second, we
xamined the relationship based on whether AMI patients
ad ST-segment elevation or not. Finally, we modified the
RACE risk score to include other comorbidities. In all of ihe above additional analyses, our overall results did not
hange significantly.
We conducted the statistical analyses using SAS software
ersion 9.1 (SAS Institute, Cary, North Carolina). All
tatistical tests were 2 tailed. Use of the NHC project
atabase was approved by the Yale University School of
edicine Human Investigation Committee.
esults
aseline characteristics, procedure indications, and re-
ional intensity. The study cohort consisted of 44,639
edicare beneficiaries who were hospitalized with AMI.
he mean age of the cohort was 78.4 years; 51.2% were
emale; 27.9% had ST-segment elevation (Table 1). Demo-
raphic and clinical characteristics of AMI patients hospi-
alized in different invasive-intensity regions were not sub-
tantially different (Table 1). The AMI patients in high-
nvasive regions were most often admitted to hospitals that
ad advanced cardiac invasive facilities (32.5% in low
nvasive intensity regions, 40.1% in intermediate invasive
ntensity regions, and 50.1% in high invasive intensity
egions; p  0.001) (Table 1).
The proportion of AMI patients who had ACC/AHA class
indication for cardiac catheterization was slightly higher
mong those hospitalized in lower invasive intensity regions
45.6% vs. 43.6% in intermediate invasive intensity regions vs.
1.9% in high invasive intensity regions; p  0.001) (Fig. 1).
onversely, the proportion of AMI patients who had class II
ndications was slightly higher among those hospitalized in
igher-intensity regions. The proportion of patients who had
lass III indication for cardiac catheterization was not substan-
ially different among the regions (Fig. 1).
ardiac catheterization, procedure appropriateness, and
egional intensity. Overall, 39% of the patients underwent
ardiac catheterization within 60 days of AMI, and there
as significant geographic variation across the U.S. (Fig. 2).
ardiac catheterization rates were 45.1% among patients
ho had ST-segment elevation AMI and 36.6% among
atients who had non–ST-segment elevation AMI. Cardiac
atheterization rates were 41.7% among patients who had
lass I indications, 39.1% among patients who had class II
ndications, and 19.8% among patients who had class III
ndications. High invasive intensity regions had the highest
ates of unadjusted and adjusted use of cardiac catheteriza-
ion among AMI patients in each of the ACC/AHA
rocedure classes (Figs. 3A and 3B). High invasive intensity
egions also had the unadjusted highest rates of coronary
evascularization within 60 days of an AMI (21.3% in
ow-intensive regions, 24.3% in intermediate-intensive re-
ions, 28.2% in high-intensive regions; p  0.001).
Higher invasive intensity regions had a 38% increased RR
1.38, 95% confidence interval [CI] 1.27 to 1.48) of per-
orming cardiac catheterization among class I patients, 42%
ncreased RR (1.42, 95% CI 1.31 to 1.53) among class II
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February 19, 2008:716–23 Cardiac Catheterization and Baseline Riskatients, and 19% increased RR (1.29, 95% CI 0.97 to 1.67)
mong class III patients compared with low invasive inten-
ity regions after adjusting for clinical and physician char-
cteristics (Table 2). Similarly, intermediate invasive inten-
ity regions had increased RRs of performing cardiac
atheterization compared with low-invasive regions among
atients who had class I (RR 1.19, 95% CI 1.09 to 1.29) and
lass II indications (RR 1.18, 95% CI 1.08 to 1.28) but not
mong class III patients (RR 0.95, 95% CI 0.70 to 1.26)
Table 2). We did not observe significant interaction be-
ween regional invasive intensity and procedure appropri-
teness level in predicting the overall use of cardiac cathe-
haracteristics of Acute Myocardial Infarction Patients Based on R
Table 1 Characteristics of Acute Myocardial Infarction Patient
Characteristics
Total
(n  44,639) (n
n % n
Demographics
Mean age, yrs 78.4 (0.05)
Age category, yrs
65–74 15,761 34.5 5,97
75–84 19,035 42.7 7,42
85 9,843 22.7 4,01
Female gender 22,439 51.2 8,61
White 37,999 86.3 14,28
Admission characteristics
Mean systolic blood pressure, mm Hg 143.4 (0.21) 1
Mean diastolic blood pressure, mm Hg 77.0 (0.15)
Mean heart rate, beats/min 89.7 (0.16)
Mean creatinine, mg/dl 1.5 (0.01)
Cardiogenic shock (or shock) 619 1.4 27
ST-segment elevation 12,822 27.9 5,18
Renal failure (creatinine 2.5 mg/dl,
BUN 40 mg/dl)
6,604 15.8 2,61
Cardiac risk factors and comorbidities
Hypertension 31,288 71.4 12,06
Diabetes 14,416 33.4 5,46
Current smoker 6,815 15.3 2,49
Prior MI 15,999 36.5 6,26
Prior CABG 7,578 17.5 2,78
Prior PCI 5,625 12.8 1,98
Prior stroke or TIA 8,313 19.2 3,04
COPD 10,451 24.0 3,86
Mean GRACE risk score 167.3 (0.24) 1
Hospital characteristics
Hospital cardiac facility
Cardiac surgery suite 17,721 41.1 5,91
Cardiac catheterization lab 9,026 20.2 3,48
No invasive facilities 12,079 23.7 5,52
Unknown 5,813 15.0 2,48
Nonteaching hospital 28,789 65.5 11,06
Mean hospital beds 314.4 (7.5) 2
Mean MI volume 21.6 (0.69)
Cardiologist 11,641 23.4 4,63
ean values presented with standard error in parentheses.
BUN  blood urea nitrogen; CABG  coronary artery bypass grafting; COPD  chronic obstruct
CI  percutaneous coronary intervention; TIA  transient ischemic attack.erization. eardiac catheterization, baseline risk, and regional in-
ensity. Figures 4 and 5 illustrate the relationship be-
ween utilization of cardiac catheterization and baseline
isk of AMI patients estimated by GRACE risk score in
ach invasive region. In all invasive regions, lower utili-
ation of cardiac catheterization was observed with pro-
ressively higher baseline risk. On average, the use of
ardiac catheterization was 5.2% lower for each decile
ncrease in the GRACE risk score. This relationship
xisted across the full spectrum of baseline risk among all
MI patients (Fig. 4) and among patients who had class
indications (Fig. 5). Furthermore, rather than prefer-
nal Invasive Intensity
ed on Regional Invasive Intensity
ity
,411)
Intermediate
Intensity
(n  14,963)
High
Intensity
(n  12,265)
p Value% n % n %
.09) 78.2 (0.08) 78.3 (0.10) 0.001
0.001
32.8 5,335 35.6 4,455 34.9
43.1 6,425 42.4 5,186 42.8
24.1 3,203 22.0 2,624 22.3
50.6 7,616 51.8 6,211 51.1 0.279
85.2 13,055 86.7 10,655 86.8 0.098
.37) 143.6 (0.35) 143.2 (0.39) 0.705
.25) 77.0 (0.24) 76.7 (0.26) 0.273
.28) 89.8 (0.27) 90.0 (0.29) 0.228
.01) 1.5 (0.04) 1.5 (0.01) 0.614
1.7 207 1.4 139 1.1 0.005
28.9 4,274 28.0 3,363 26.7 0.010
15.9 2,160 15.7 1,834 15.8 0.887
70.3 10,563 72.1 8,659 71.6 0.018
32.5 4,935 34.1 4,016 33.4 0.068
13.9 2,319 15.7 2,006 15.9 0.001
37.4 5,408 35.8 4,330 36.5 0.090
16.4 2,500 16.8 2,294 19.2 0.001
11.6 1,919 12.4 1,724 14.3 0.001
17.8 2,819 19.3 2,451 20.2 0.001
22.6 3,689 24.9 2,901 24.3 0.002
.42) 167 (0.38) 166.6 (0.43) 0.001
0.001
32.5 5,688 40.1 6,117 50.1
18.7 3,400 22.2 2,146 19.2
30.4 4,015 23.4 2,538 18.1
18.4 1,860 14.3 1,464 12.6
63.6 9,378 65.7 8,344 67.2 0.436
1.1) 311.3 (9.7) 341.9 (15.1) 0.011
.01) 20.7 (1.23) 20.8 (1.18) 0.076
23.6 3,957 23.7 3,050 22.9 0.683
onary disease; GRACE  Global Registry of Acute Coronary Events; MI  myocardial infarction;egio
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Cardiac Catheterization and Baseline Risk February 19, 2008:716–23egions performed more procedures across the entire risk
pectrum.
ortality by regional invasive intensity. Risk-standardized
ortality rates were not significantly different at 3 years after
MI hospitalization (46.7% [95% CI 45.5% to 47.9%] in
ow-intensity regions vs. 47.5% [95% CI 46.3% to 48.7%] in
ntermediate-intensity regions vs. 48.6% [95% CI 47.3% to
0.0%] in high-intensity regions; p  0.22).
iscussion
n this large cohort of hospitalized AMI patients, we found
hat the highest invasive intensity regions performed more
Figure 1 ACC/AHA Procedure
Appropriateness by Regional Invasive Intensity
ACC  American College of Cardiology; AHA  American Heart Association.
Figure 2 Unadjusted Rates of Cardiac CatheterizationgAfter Acute Myocardial Infarction in the U.S.ardiac catheterizations among patients who had class I
ndications, that is, procedures that were considered useful
nd effective or appropriate. To a lesser extent, we also
ound that the highest invasive intensity regions performed
ore cardiac catheterizations among patients with class III
ndications, procedures that were considered to be ineffec-
ive or inappropriate. Furthermore, none of the regions
elected higher baseline risk patients for cardiac catheter-
zations after AMI. As a result, cardiac catheterization is
sed most frequently in the lowest-risk patients and least
requently in the highest-risk patients. Finally, hospitaliza-
ion of AMI patients in higher invasive intensity regions
as not associated with better long-term mortality com-
ared with hospitalization in lower-intensity regions.
Previous studies examining whether appropriateness of car-
iac invasive procedures relates to invasive intensity have been
nconsistent (9–12). In a study comparing the appropriateness
f coronary angiography and coronary artery bypass surgery
etween New York State and Canada, McGlynn et al. (9)
emonstrated that the proportion of appropriate and inappro-
riate patients who underwent these procedures was similar. In
ontrast, other data have shown that AMI patients with class
indications are less likely to receive cardiac catheterization in
he managed care or the Veterans Affairs health care system,
oth of which have less procedural capacity compared with
ee-for-service systems (10,11). Our findings confirmed that
igher invasive intensity regions performed more cardiac cath-
terizations among class I AMI patients. Unlike many other
tudies, we also found that higher invasive intensity regions
erformed more procedures among class III patients, a sub-
Figure 3 Rates of Cardiac Catheterization According
to ACC/AHA Class and Regional Invasive Intensity
(A) Unadjusted and (B) adjusted rates. Abbreviations as in Figure 1.roup in which the procedure is considered inappropriate.
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February 19, 2008:716–23 Cardiac Catheterization and Baseline RiskAnother major finding was the discordant utilization
attern of cardiac catheterization compared with guideline
ecommendations (2,3). In this study, cardiac catheteriza-
ion use among class I AMI patients was only 42%, and the
tilization rate was 20% among class III patients. National
ocieties such as the ACC and the AHA have invested
ubstantial efforts to develop practice guidelines to assist
hysicians in AMI management (2,3). These efforts are
ikely responsible in part for the dramatic improvements in
he use of evidence-based medical therapy. Yet, the signif-
cant discordant treatment patterns we observed raise con-
erns about the uptake and acceptance of these guideline
ecommendations in cardiac interventional management,
hich are more difficult to implement than prescribing
edical therapy in clinical practice. Ongoing efforts to
evelop appropriateness criteria for cardiac catheterization
Adjusted Utilization of Cardiac Catheterization b
Table 2 Adjusted Utilization of Cardiac Cath
Description Lo
Adjusting for clinical characteristics*
Overall
Strong (class I)
Equivocal (class II)
Strong or equivocal (class I or II)
Weak (class III)
Adjusting for clinical and physician characteristics†
Overall
Strong (class I)
Equivocal (class II)
Strong or equivocal (class I or II)
Weak (class III)
Values are presented as relative risk (95% confidence interval). *Clin
serum creatinine, cardiac resuscitation, ST-segment elevation, cardia
urinary continence. †Clinical and physician model adjusted for clinica
Figure 4 Relationship of Cardiac Catheterization
and Risk by Regions Among All Patients
AMI  acute myocardial infarction;
GRACE  Global Registry of Acute Coronary Events.nd coronary revascularization may provide a better frame-
ork that can be better applied in clinical practice.
Although the relative and absolute survival benefits asso-
iated with cardiac catheterization after AMI have been
hown to positively correlate with baseline risk (26), no
tudy to our knowledge has evaluated whether higher-
nvasive regions optimize the use of coronary angiography
hrough selection of higher-risk patients. We found that
igher-invasive regions performed more cardiac catheteriza-
ions across the entire risk spectrum without taking into
onsideration the potential added benefit among higher-risk
atients. We also found a pattern of risk avoidance in which
ardiac catheterization rates progressively declined as base-
ine risk increased. The practice pattern of diminishing
tilization of effective therapy in higher-risk patients has
een shown previously and termed the “treatment-risk
aradox” (6,27). Because the majority of procedures are
oncentrated among lower-risk patients, where only small
gional Invasive Intensity
zation by Regional Invasive Intensity
nsity Intermediate Intensity High Intensity
ef) 1.17 (1.09–1.26) 1.37 (1.28–1.47)
ef) 1.19 (1.10–1.29) 1.36 (1.26–1.47)
ef) 1.17 (1.07–1.27) 1.40 (1.29–1.51)
ef) 1.18 (1.09–1.27) 1.37 (1.28–1.47)
ef) 1.00 (0.75–1.32) 1.34 (1.02–1.72)
ef) 1.18 (1.10–1.26) 1.39 (1.30–1.48)
ef) 1.19 (1.09–1.29) 1.38 (1.27–1.48)
ef) 1.18 (1.08–1.28) 1.42 (1.31–1.53)
ef) 1.18 (1.10–1.27) 1.39 (1.30–1.48)
ef) 0.95 (0.70–1.26) 1.29 (0.97–1.67)
del adjusted for age, Killip class, systolic blood pressure, heart rate,
es, chronic obstructive pulmonary disease, dementia, mobility, and
teristics and physicians’ age, gender, race, and specialty.
Figure 5 Relationship of Cardiac Catheterization
and Risk by Region Among Class I Patients
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n explanation as to why previous studies have not been able
o demonstrate survival benefits of an invasive therapy in
linical practice (5,6,28–30). There remains a need to
nderstand how to optimize the effectiveness of an invasive
herapy in clinical practice.
tudy limitations. Several limitations of our study merit
onsideration. First, we were unable to identify the reasons
nderlying the discordant treatment-risk relationship.
owever, it has been suggested that in treating higher-risk
atients with multiple comorbidities, many factors often
ead to a “hands-off” approach in which interventional
rocedures are often withheld from higher-risk patients
31). Second, our findings are specific to the patient popu-
ation and the time period studied, but there is no informa-
ion to suggest that these patterns have changed since then.
inally, we used practice guidelines developed by the 1996
CC/AHA guidelines (20) to classify cardiac catheteriza-
ion indications to reflect practice recommendations when
his study cohort was assembled and to promote compari-
ons of the findings with previous studies. One of the major
hanges of contemporary guidelines relates to the endorse-
ent of routine cardiac catheterization among non–ST-
egment elevation AMI. Therefore, we performed addi-
ional analyses combining AMI patients who had class I and
lass II procedure indications and found similar results.
onclusions
ur study shows that variation in the use of cardiac
atheterization occurs without regard for the strength of
ndication for the procedure. Higher-utilization regions
erform more indicated, nonindicated, and discretionary
rocedures than lower-utilization regions. The higher rates
re not differentially the result of performing more proce-
ures in the patients with the strongest indications. This
attern may account, in part, for the lack of a strong
ssociation between the use of procedures and better outcomes.
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APPENDIX
or a table of the ACC/AHA appropriateness criteria for cardiac catheter-
zation, please see the online version of this article.
